Atrium Therapeutics raises about $50 million in PIPE

Atrium Therapeutics said it will sell shares and pre-funded warrants in a private investment in public equity expected to raise about $50 million in gross proceeds at about $7.93 per share, under a securities purchase agreement signed Oct. 7, 2026.